State Street’s Redhill Biopharma RDHL Stock Holding History

State Street’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-52	Closed	-$45K	–	4949
2022 Q2	$45K	Hold	52	–	–	﹤0.01%	4743
2022 Q1	$131K	Buy	52 +3	+6%	+$7.11K	﹤0.01%	4548
2021 Q4	$127K	Buy	49 +2	+4%	+$8K	﹤0.01%	4519
2021 Q3	$216K	Sell	47 -63	-57%	-$427K	﹤0.01%	4329
2021 Q2	$754K	Buy	110 +16	+17%	+$110K	﹤0.01%	3720
2021 Q1	$690K	Sell	94 -17	-15%	-$143K	﹤0.01%	3690
2020 Q4	$939K	Buy	111 +9	+9%	+$80.9K	﹤0.01%	3562
2020 Q3	$1.04M	Buy	102 +90	+750%	+$738K	﹤0.01%	3419
2020 Q2	$80K	Sell	12 -82	-87%	-$565K	﹤0.01%	3673
2020 Q1	$426K	Buy	94 +14	+18%	+$70K	﹤0.01%	3475
2019 Q4	$484K	Buy	+80	New	+$511K	﹤0.01%	3528

Other funds holding RDHL

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

State Street's RDHL Position: Q3 2022 in Review

State Street sold out of Redhill Biopharma (RDHL) in Q3 2022, closing a stake of 52 shares — an estimated $45K sold.

State Street first reported a position in RDHL in Q4 2019 and held it in 11 quarters. The position peaked at $1.04M in Q3 2020. 40 funds tracked by Wall St. Rank hold RDHL as of Q3 2022.

State Street reported no remaining Redhill Biopharma position as of Q3 2022 after selling out during the quarter.
State Street sold 52 Redhill Biopharma shares in Q3 2022, an estimated $45K.
State Street first reported a position in Redhill Biopharma in Q4 2019 and held it in 11 quarters.
State Street's Redhill Biopharma position peaked at $1.04M in Q3 2020.
40 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.